Literature DB >> 3395921

A comparative study of two preservative-free tear substitutes in the management of severe dry eye.

M Y Laflamme1, R Swieca.   

Abstract

Between mid-May and mid-July 1987 we performed a prospective crossover study of two unit-dose preservative-free artificial tear solutions, 1.4% polyvinyl alcohol (Refresh) and 0.1% sodium hyaluronate (Hylorin) in 14 female patients with severe dry eye syndrome. The patients were examined before treatment and after each of two trials with both products. A significant reduction in the mean score for dry-eye-induced keratitis (p = 0.001) and for mucous strands (p = 0.03) was observed following the second of two trials with sodium hyaluronate. A significant reduction in the mean score for burning and irritation was observed with both solutions (p = 0.009). We believe that the elimination of preservatives from artificial tear preparations may substantially reduce the iatrogenic effects of these frequently applied medications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3395921

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  10 in total

1.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

Authors:  P J Pisella; P Pouliquen; C Baudouin
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 2.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

3.  Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor.

Authors:  Maria Grazia Sammarco; Monica Maria Pagliara; Gustavo Savino; Federico Giannuzzi; Matteo Mario Carlà; Carmela Grazia Caputo; Maria Antonietta Blasi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-08       Impact factor: 4.322

4.  Effects of artificial tears on corneal epithelial permeability in dry eyes.

Authors:  M Göbbels; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

Review 5.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

6.  Control of microbial contamination in unpreserved eyedrops.

Authors:  G B Oldham; V Andrews
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

7.  Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

Authors:  Yuri S Astakhov; Sergei Y Astakhov; Alla B Lisochkina
Journal:  Clin Ophthalmol       Date:  2013-12-09

8.  Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Bryan Chin Hou Ang; James Jie Sng; Priscilla Xin Hui Wang; Hla Myint Htoon; Louis Hak Tien Tong
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 9.  A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome.

Authors:  Yun-Jung Yang; Won-Young Lee; Young-Jin Kim; Yeon-Pyo Hong
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

10.  Evaluation of the Lubricating Effect of Hyaluronic Acid on Contact Lenses Using a Pendulum-Type Friction Tester Under Mimicking Physiological Conditions.

Authors:  Hiroko Iwashita; Kiyoshi Mabuchi; Takashi Itokawa; Yukinobu Okajima; Takashi Suzuki; Yuichi Hori
Journal:  Eye Contact Lens       Date:  2022-02-01       Impact factor: 2.018

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.